Founded in 2013, Xie Nuo Investment is a frontier technology investment institution driven by industrial research. It has long seized scientific and technological innovation investment opportunities originating from academia and industry, with business layout covering securities investment, equity investment, overseas investment and other fields, and its venture capital fund management scale exceeds RMB 10 billion.
Xie Nuo Investment's investment research team has abundant industrial resources and complete industry coverage. Its equity fund management subsidiary (Xie Nuo Chen Tu) adheres to the investment strategy of "industry research-driven + lead investment empowerment", deeply cultivating high-prosperity industries. It has formed a layout in key fields of strategic emerging industries such as new energy, semiconductors/new materials, healthcare, and artificial intelligence, and has invested in more than 50 high-tech and advanced manufacturing enterprises including YMTC and Xinxin Semiconductor, among which 18 leading enterprises in sub-sectors, including CATL, SiEn Integration, CALB, and Lianyun Technology, have been successfully listed in the capital market (14 on A-shares, 1 on US stocks, and 3 on Hong Kong stocks).
Its private securities fund management subsidiary (Xie Nuo Chen Yang) is rooted in the industrial chain, sharing the value growth of excellent enterprises in the new economy field with PE thinking, and has built a diversified product line and investment research system for investment strategies such as Juvy anti-fragility, high growth, and the pharmaceutical industry.
In addition, Xie Nuo Investment established the Xie Nuo Industrial Research Institute, bringing together master's and doctoral degree holders from well-known domestic and international universities and research institutions, as well as external expertise from government, industry, academia, and research. Furthermore, Xie Nuo established the AI+X Future Industry Joint Innovation Center, combining the innovative forces of industrial companies and capital companies to improve the efficiency of technology-to-commercial transformation. Currently, in the field of AI + biomedicine, it has gathered a number of outstanding enterprises such as Aolvxin, Bairui Medical, Yizhun Intelligent, Deruizhi Drug, and Molecule Mind, jointly building industry-level technology platforms and service platforms.
What does Guangzhou Xie Nuo Investment Group Co., Ltd. require? Who is Xie Nuo Investment hiring? Xie Nuo Investment recruitment: 市场/公关/媒介类占比最多占34.8%，其次是财务/审计/统计类占26.1%. What education can get in at Xie Nuo Investment? 本科占比最多占52.2%，其次是硕士占21.7%. High education required at Xie Nuo Investment? 硕士占21.7%，博士占13%. Work experience required at Xie Nuo Investment? 1-3年占比最多占30.4%，其次是3-5年占26.1%. Where are the job locations at Xie Nuo Investment? 广州占比最多占100%. Based on job postings from the past year, for reference only.
Provided by
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
